Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 6;33(4):254.
doi: 10.1007/s00520-025-09317-9.

Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment

Affiliations

Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment

Raymond J Chan et al. Support Care Cancer. .

Abstract

Purpose: This study reports on the results from our data-driven approach that identified perturbations in neuroactive ligand-receptor interaction and renin-angiotensin system (RAS) pathways in oncology patients with and without self-reported cancer-related cognitive impairment (CRCI).

Methods: In a sample of oncology patients receiving chemotherapy (n = 1343), the Attentional Function Index (AFI) was used to assess CRCI. Patients were grouped into low (AFI score of < 5) versus high (AFI score of > 7.5) levels of cognitive function. Gene expression analyses were done using RNA-seq (n = 185) and microarray (n = 158) technologies. Pathway impact analysis was used to evaluate for perturbations in biological pathways associated with self-reported CRCI.

Results: The combined pathway impact analysis revealed that the neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed between the patients with low versus high AFI scores.

Conclusions: Findings from this study suggest that in addition to inflammatory pathways, numerous mechanisms may contribute to the underlying mechanisms for the development and/or persistence of self-reported CRCI.

Keywords: Cancer; Chemotherapy; Cognitive dysfunction; Cognitive impairment; Neuroinflammation; Renin angiotensin system.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Committee on Human Research at the University of California, San Francisco. Consent to participate: Written informed consent was obtained from the patients. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

Cited by

References

    1. Cerulla Torrente N, Navarro Pastor JB, de la Osa CN (2020) Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy. J Cancer Surviv 14(4):464–482. 10.1007/s11764-020-00870-2 - PubMed
    1. Klaver KM, Duijts SFA, Engelhardt EG, Geusgens CAV, Aarts MJB, Ponds R et al (2020) Cancer-related cognitive problems at work: experiences of survivors and professionals. J Cancer Surviv 14(2):168–178. 10.1007/s11764-019-00830-5 - PMC - PubMed
    1. Tan CJ, Yip SYC, Chan RJ, Chew L, Chan A (2021) Investigating how cancer-related symptoms influence work outcomes among cancer survivors: a systematic review. J Cancer Surviv. 10.1007/s11764-021-01097-5 - PMC - PubMed
    1. Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 23(10):2547–2552. 10.1093/annonc/mds029 - PubMed
    1. Ren X, Boriero D, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochimica et Biophysica Acta (BBA) – Mol Basis Dis 1865(6):1088–97. 10.1016/j.bbadis.2019.02.007 - PMC - PubMed